MedPath

Genome-wide analysis of advanced lung cancer cases that showed marked response to chemotherapy resulting in a treatment-free long-term remissio

Not Applicable
Conditions
ung cancer, Mesothelioma
Registration Number
JPRN-UMIN000037822
Lead Sponsor
Division of Respiratory Medicine and Allergology, Aichi Medical University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
4
Inclusion Criteria

Not provided

Exclusion Criteria

1. Active double cancer (patients with treatment-free and disease-free state for 3 years or longer after a curative treatment are eligible) 2. Unsuitable to enter this study judged by an attending physician

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath